{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:30:06Z","timestamp":1783477806589,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007343","name":"Shire Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.bone.2018.11.012","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T12:33:28Z","timestamp":1542630808000},"page":"548-555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Skeletal Manifestations of Hypoparathyroidism"],"prefix":"10.1016","volume":"120","author":[{"given":"Mishaela R.","family":"Rubin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2018.11.012_bb0005","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1359\/jbmr.080803","article-title":"Dynamic and structural properties of the skeleton in hypoparathyroidism","volume":"23","author":"Rubin","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.11.012_bb0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/8756-3282(95)00443-2","article-title":"Bone histomorphometry in hypoparathyroid patients treated with vitamin D","volume":"18","author":"Langdahl","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.bone.2018.11.012_bb0015","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/jbmr.452","article-title":"PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism","volume":"26","author":"Rubin","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.11.012_bb0020","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium","volume":"88","author":"Winer","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2018.11.012_bb0025","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/jbmr.470","article-title":"The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study","volume":"26","author":"Sikjaer","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.11.012_bb0030","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/jbmr.1627","article-title":"Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure","volume":"27","author":"Gafni","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.11.012_bb0035","first-page":"1617","article-title":"Bone mineral density in patients with chronic hypoparathyroidism","volume":"76","author":"Abugassa","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2018.11.012_bb0040","first-page":"2135","article-title":"Attenuation of postmenopausal high turnover bone loss in patients with hypoparathyroidism","volume":"80","author":"Fujiyama","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2018.11.012_bb0045","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1172\/JCI110570","article-title":"Differential effects of endocrine dysfunction on the axial and the appendicular skeleton","volume":"69","author":"Seeman","year":"1982","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2018.11.012_bb0050","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00000441-199508000-00003","article-title":"Hypoparathyroidism counteracts risk factors for osteoporosis","volume":"310","author":"Touliatos","year":"1995","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.bone.2018.11.012_bb0055","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1210\/jc.2003-030470","article-title":"Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects","volume":"88","author":"Chen","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2018.11.012_bb0060","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/jbmr.1493","article-title":"Changes in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1-84): a randomized controlled study","volume":"27","author":"Sikjaer","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.11.012_bb0065","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/BF00441552","article-title":"Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment","volume":"148","author":"Kruse","year":"1989","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.bone.2018.11.012_bb0070","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1172\/JCI113690","article-title":"Effects of active vitamin D3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism","volume":"82","author":"Mizunashi","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2018.11.012_bb0075","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1210\/jc.2009-2682","article-title":"Parathyroid hormone stimulates circulating osteogenic cells in hypoparathyroidism","volume":"96","author":"Rubin","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2018.11.012_bb0080","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1210\/jc.2011-0566","article-title":"Circulating sclerostin in disorders of parathyroid gland function","volume":"96","author":"Costa","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2018.11.012_bb0085","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1210\/jcem.84.2.5498","article-title":"Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone","volume":"84","author":"Duan","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2018.11.012_bb0090","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/jbmr.2609","article-title":"Noninvasive assessment of skeletal microstructure and estimated bone strength in hypoparathyroidism","volume":"31","author":"Cusano","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.11.012_bb0095","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1210\/endo-119-3-1298","article-title":"1,25-Dihydroxyvitamin D maintains bone cell activity, and parathyroid hormone modulates bone cell number in dogs","volume":"119","author":"Malluche","year":"1986","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2018.11.012_bb0100","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bone.2009.09.020","article-title":"Three dimensional cancellous bone structure in hypoparathyroidism","volume":"46","author":"Rubin","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.bone.2018.11.012_bb0105","article-title":"Bone mineralization density and collagen cross-link ratios in hypoparathyroidism","volume":"2006","author":"Paschalis","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.11.012_bb0110","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/jbmr.2501","article-title":"The epidemiology of nonsurgical hypoparathyroidism in Denmark: a nationwide case finding study","volume":"30","author":"Underbjerg","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.11.012_bb0115","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/jbmr.1979","article-title":"Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study","volume":"28","author":"Underbjerg","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.bone.2018.11.012_bb0120","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/jbmr.2273","article-title":"Post-surgical hypoparathyroidism - risk of fractures, psychiatric diseases, cancer, cataract, and infections","volume":"29","author":"Underbjerg","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.11.012_bb0125","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1210\/jc.2012-1808","article-title":"Long-term follow-up of patients with hypoparathyroidism","volume":"97","author":"Mitchell","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2018.11.012_bb0130","first-page":"251","article-title":"Vertebral fractures and bone mineral density in patients with idiopathic hypoparathyroidism on long-term follow-up","volume":"102","author":"Chawla","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2018.11.012_bb0135","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00198-009-0945-7","article-title":"Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy","volume":"21","author":"Cohen","year":"2010","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2018.11.012_bb0140","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1210\/jc.2012-2984","article-title":"Therapy of hypoparathyroidism with PTH(1-84): a prospective four-year investigation of efficacy and safety","volume":"98","author":"Cusano","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2018.11.012_bb0145","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1210\/jc.2015-4135","article-title":"Therapy of hypoparathyroidism with PTH(1-84): a prospective six year investigation of efficacy and safety","volume":"101","author":"Rubin","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2018.11.012_bb0150","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study","volume":"1","author":"Mannstadt","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bone.2018.11.012_bb0160","article-title":"Five-year efficacy and safety of recombinant human parathyroid hormone 1-84 (rhPTH[1-84]) for the treatment of adults with chronic hypoparathyroidism: analysis from the open-label race study","volume":"39","author":"Shoback","year":"2018","journal-title":"Endocr. Rev."},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2018.11.012_bb0165","article-title":"Bone turnover in patients with hypoparathyroidism treated for 5\u202fyears with recombinant human parathyroid hormone, rhPTH(1\u201384), in the open-label RACE study","volume":"33","author":"Mannstadt","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.11.012_bb0170","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1210\/jc.2011-1908","article-title":"Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism","volume":"97","author":"Winer","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2018.11.012_bb0175","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jpeds.2014.04.060","article-title":"Effects of pump versus twice-daily injection delivery of synthetic parathyroid hormone 1-34 in children with severe congenital hypoparathyroidism","volume":"165","author":"Winer","year":"2014","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bone.2018.11.012_bb0180","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1210\/jc.2009-2464","article-title":"Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium","volume":"95","author":"Winer","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2018.11.012_bb0185","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1359\/JBMR.051109","article-title":"A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide","volume":"21","author":"Lindsay","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.11.012_bb0190","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/jbmr.2777","article-title":"Effects of parathyroid hormone administration on bone strength in hypoparathyroidism","volume":"31","author":"Rubin","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.11.012_bb0195","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jbmr.2588","article-title":"PTH(1-84) administration in hypoparathyroidism transiently reduces bone matrix mineralization","volume":"31","author":"Misof","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.bone.2018.11.012_bb0200","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/jbmr.3543","article-title":"The effects of long-term administration of rhPTH(1-84) in hypoparathyroidism by bone histomorphometry","volume":"33","author":"Rubin","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.11.012_bb0205","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2131\/jts.37.617","article-title":"Osteosarcoma in Sprague-Dawley rats after long-term treatment with teriparatide (human parathyroid hormone (1-34))","volume":"37","author":"Watanabe","year":"2012","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.bone.2018.11.012_bb0210","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/01926230601072301","article-title":"Defining a noncarcinogenic dose of recombinant human parathyroid hormone 1-84 in a 2-year study in Fischer 344 rats","volume":"34","author":"Jolette","year":"2006","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.bone.2018.11.012_bb0215","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1359\/jbmr.081233","article-title":"PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation","volume":"24","author":"Theman","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.11.012_bb0220","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","article-title":"A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery","volume":"341","author":"Silverberg","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2018.11.012_bb0225","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/jbmr.1768","article-title":"The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7\u202fyears","volume":"27","author":"Andrews","year":"2012","journal-title":"J. Bone Miner. Res."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328218304344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328218304344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T09:38:15Z","timestamp":1565257095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328218304344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":44,"alternative-id":["S8756328218304344"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2018.11.012","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skeletal Manifestations of Hypoparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2018.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}